Trust Company of Vermont’s Pediatrix Medical MD Stock Holding History

Trust Company of Vermont’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-150	Closed	-$10K	–	931
2016 Q3	$10K	Hold	150	–	–	﹤0.01%	669
2016 Q2	$11K	Buy	+150	New	+$10.3K	﹤0.01%	597
2015 Q1	–	Sell	-140	Closed	-$9K	–	788
2014 Q4	$9K	Hold	140	–	–	﹤0.01%	653
2014 Q3	$8K	Buy	+140	New	+$7.94K	﹤0.01%	674

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Trust Company of Vermont's MD Position: Q4 2016 in Review

Trust Company of Vermont sold out of Pediatrix Medical (MD) in Q4 2016, closing a stake of 150 shares — an estimated $10K sold.

Trust Company of Vermont first reported a position in MD in Q3 2014 and held it in 4 quarters. The position peaked at $11K in Q2 2016. 383 funds tracked by Wall St. Rank hold MD as of Q4 2016.

Trust Company of Vermont reported no remaining Pediatrix Medical position as of Q4 2016 after selling out during the quarter.
Trust Company of Vermont sold 150 Pediatrix Medical shares in Q4 2016, an estimated $10K.
Trust Company of Vermont first reported a position in Pediatrix Medical in Q3 2014 and held it in 4 quarters.
Trust Company of Vermont's Pediatrix Medical position peaked at $11K in Q2 2016.
383 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2016.

Based on Trust Company of Vermont's 13F filing for Q4 2016, filed 1 Feb 2017.